Leucomentin-5
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Enzyme inhibitors |
| Catalog number | BBF-02256 |
| CAS | |
| Molecular Weight | 698.67 |
| Molecular Formula | C38H34O13 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
It is produced by the strain of Paxillus panuoides. It is a free radical scavenger. It has strong inhibitory effect of lipid peroxidation with IC50 of 0.11 μg/mL. The IC50 of reference Leucomentin-2 is 0.06 μg/mL.
- Specification
- Properties
- Reference Reading
- Price Product List
| IUPAC Name | [2-acetyloxy-3,6-bis(4-hydroxyphenyl)-4,5-bis[[(Z)-3-[(2R,3S)-3-methyloxiran-2-yl]prop-2-enoyl]oxy]phenyl] (Z)-3-[(2R,3S)-3-methyloxiran-2-yl]prop-2-enoate |
| Canonical SMILES | CC1C(O1)C=CC(=O)OC2=C(C(=C(C(=C2OC(=O)C)C3=CC=C(C=C3)O)OC(=O)C=CC4C(O4)C)OC(=O)C=CC5C(O5)C)C6=CC=C(C=C6)O |
| InChI | InChI=1S/C38H34O13/c1-19-27(45-19)13-16-30(42)49-36-34(24-7-11-26(41)12-8-24)38(51-32(44)18-15-29-21(3)47-29)37(50-31(43)17-14-28-20(2)46-28)33(35(36)48-22(4)39)23-5-9-25(40)10-6-23/h5-21,27-29,40-41H,1-4H3/b16-13-,17-14-,18-15-/t19-,20-,21-,27+,28+,29+/m0/s1 |
| InChI Key | QPGKQDNGSJHXHK-YQZLAJEPSA-N |
| Appearance | Gray Powder |
| Solubility | Soluble in Methanol |
| BBF-00693 | Ansamitocin P-3 | Inquiry |
| BBF-03794 | Geneticin sulfate | Inquiry |
| BBF-02594 | Pyrrolnitrin | Inquiry |
| BBF-03963 | Pristinamycin | Inquiry |
| BBF-00703 | Carminomycin I | Inquiry |
| BBF-05827 | Spliceostatin A | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
